Can we engineer the end of ageing? | Daisy Robinton |

Can we engineer the end of ageing? | Daisy Robinton |
I wouldn't mind giving her a DNA sample ..

Harvard University biologist Daisy Robinton reveals how science is helping us understand how and why we age.

Daisy Robinton is a scientist at Harvard University researching mechanisms of stem cell identity at the intersection of cancer and developmental biology. Daisy’s passion for the effective translation of science has fuelled her years of teaching and speaking, and in 2011 Daisy founded the Science in the News Spring Public Lecture Series at Harvard. Daisy consults to numerous biotech startups in the US and UK and for projects ranging from feature film screenplays on the future of medicine and longevity to the “Future of Making” via bioengineering with IDEO.

Reverse Aging | Dr. Shai Efrati |

Reverse aging, taking the biology back in time, can be achieved by inducing the body for self rejuvenation.

Dr. Shai Efrati: Director of the Sagol Center for Hyperbaric Medicine and Research, Assaf-Harofeh Medical
Under the management and guidance of Dr. Efrati, the Sagol Center for Hyperbaric Medicine and Research has become the largest most occupied hyperbaric center in the world, currently treating more than 120 patients a day. Dr. Efrati initiated a research program focusing on the neuroplasticity (regeneration of brain tissue) of Hyperbaric Oxygen Therapy (HBOT). In the first clinical study it was proved that HBOT can induce neuroplasticity in stroke and traumatic brain injuries even years after an acute incident. The vital clinical results gained from the research program have shed fascinating new light on regeneration of the injured brain as well as aging tissues.

Can we stop aging? | Andrei Gudkov

Scientist and expert Dr. Andrei Gudkov tells us what aging really is, how and why it happens, and what our future might be. What is the key to longer, healthier lives, and is it in our reach?

Andrei is a preeminent cancer researcher, Senior Vice President for Basic Science; Chair of the Department of Cell Stress Biology, and a member of the senior leadership team for National Cancer Institute (NCI) Cancer Center Support Grant at Roswell Park Cancer Institute (RPCI). He is responsible for building on the basic and translational research strengths of the Cell Stress Biology program in DNA damage and repair, photodynamic therapy, thermal and hypoxic stress and immune modulation. Andrei was formerly at the Lerner Research Institute, Cleveland Clinic Foundation, where he served as Chair of the Department of Molecular Genetics and professor of biochemistry at Case Western Reserve University. He earned his doctoral degree in Experimental Oncology at the Cancer Research Center, USSR and a Doctorate of Science (D.Sci) in Molecular Biology at the Moscow State University, USSR. He has authored or co-authored 218 scientific articles, holds 54 patents and co-founded six biotech companies, including Everon Biosciences, Inc. that develops antiaging drugs.

A Medical Revolution: Targeting aging directly | Brian Kennedy | TEDxOnBoard

Internationally recognized for his research in the basic biology of aging and as a visionary committed to translating research discoveries into new ways of delaying, detecting, preventing and treating human aging and associated diseases. Aging research has recently identified a number of promising strategies that may slow human aging. Given that (1) 20% of humans on Earth will be over 60 in the near future, (2) aging is the biggest risk factor for the vast majority of chronic diseases that reduce quality of life in adults, and (3) effective therapies for aging are likely to prevent many chronic diseases simultaneously, I make the case that it is critical to test longevity strategies in human populations as soon as possible. @BKennedy_aging

Dr. Brian Kennedy is internationally recognized for his research in the basic biology of aging and as a visionary committed to translating research discoveries into new ways of delaying, detecting, preventing and treating human aging and associated diseases. From 2010 to 2016 he was the President and CEO of the Buck Institute for Research on Aging. Currently he remains as a Professor at the Institute, has appointments at a number of other Universities and is actively involved with Biotechnology companies focused on aging. http://www.buckinstitute.org/